, Tracking Stock Market Picks
Enter Symbol:
M.d.c. Holdings, Inc. (MDC) [hlAlert]

down 4.96 %

M.d.c. Holdings, Inc. (MDC) rated Buy with price target $43 by Deutsche Bank

Posted on: Monday,  Nov 18, 2013  1:25 PM ET by Deutsche Bank

Deutsche Bank rated Buy M.d.c. Holdings, Inc. (NYSE: MDC) on 11/18/2013. Previously Deutsche Bank rated Buy M.d.c. Holdings, Inc. (NYSE: MDC) on
01/13/2011., when the stock price was $30.02. Since then, M.d.c. Holdings, Inc. has lost 4.96% as of 01/20/2016's recent price of $28.53.
If you would have followed the previous Deutsche Bank's recommendation on MDC, you would have lost 4.96% of your investment in 1833 days.

Medicines Company acquires, develops and commercializes biopharmaceutical products in late stages of development. U.S. Food and Drug Administration intends to approve its first product, Angiomax, for use in the treatment ofpatients with unstable angina undergoing coronary balloon angioplasty. The company is also developing Angiomax for additional potential applications for use in the treatment of ischemic heart disease, a condition which occurs when organs receive an inadequate supply of oxygen as a result of decreased blood flow.

Deutsche Bank is one of the largest European fund managers. DWS was founded in 1956 and is an integral part of the Asset Management division of Deutsche Bank. This division is one of the largest global asset managers.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/18/2013 1:25 PM Buy
29.11 43.00
as of 12/13/2013
1 Week down  -2.07 %
1 Month up  2.41 %
3 Months down  -2.46 %
1 YTD down  -21.57 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/5/2013 2:25 PM Buy
38.94 45.00
8/19/2011 1:25 PM Buy
17.02 34.00
1/13/2011 1:25 PM Buy
30.02 42.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy